Perspectives on current treatment modalities for older patients with acute myeloid leukemia (AML)

and those who are unfit for intensive chemotherapy: insights after ASH 2020

Learning objective:

After participating in this webinar, viewers should be able to:

  • Discuss the data from ASH2020 relating to the current management of older or unfit patients with acute myeloid leukemia


Moderator: Charles Craddock (United Kingdom)



  • Uwe Platzbecker (Germany)
  • Agnieszka Wierzbowska (Poland)


More Info
47 Minutes
EM-48614 - Date of preparation: November 2020